Clinical Studies

IMBiotechnologies Ltd is currently sponsoring the following studies:

 

     An Open Label, Single Center, Pilot Study to Evaluate the Safety and Effectiveness of OCL 503 in Prostate Artery Embolization for the Treatment of Men with Benign Prostatic Hypertropy (BPH)

 

Full Study Description  - ClinicalTrials.gov

                                    (click to view)